TUESDAY, Oct. 17, 2023 (HealthDay News) -- Solriamfetol seems to be effective for management of attention-deficit/hyperactivity disorder (ADHD) in adults, according to a study published online Oct. 9 in the Journal of Clinical Psychiatry. Craig B. H. Surman, M.D., from Massachusetts General Hospital in Boston, and colleagues performed a remotely conducted, randomized, double-blind, six-week dose-optimization
Related Keywords
Boston , Massachusetts , United States , Craigbh Surman , , Healthday News , Massachusetts General Hospital , Clinical Global Impressions , Symptom Rating Scale , Behavior Rating Inventory , Global Assessment ,
vimarsana.com © 2020. All Rights Reserved.